Cardiff Oncology Set for Pivotal Investor Conference Series
02.09.2025 - 19:00:07 | boerse-global.deCardiff Oncology enters a crucial period with three major investor conferences scheduled for early September, providing the biotechnology firm with significant platforms to showcase its clinical development progress and corporate strategy.
The company maintains a robust financial position, reporting $71.0 million in cash and investments as of the end of the second quarter of 2025. With quarterly operating expenses of $14.9 million, this capital reserve is projected to fund operations through the first quarter Read more...
Hol dir jetzt den Wissensvorsprung der Aktien-Profis.
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt kostenlos anmelden
Jetzt abonnieren.
